FDA Panel Endorses Emergency Use Authorization of Merck's COVID-19 Pill, Molnupiravir
Published
FDA committee recommended Merck's COVID-19 pill molnuparivir to be approved for emergency use for treating mild-to-moderate patients.
Full ArticlePublished
FDA committee recommended Merck's COVID-19 pill molnuparivir to be approved for emergency use for treating mild-to-moderate patients.
Full ArticleMolnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus..
Watch VideoA panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage..